Our partner Verma Drugs S.A., which contributes to the continuous education of healthcare professionals, is organizing two satellite lectures therapies on 29 November in Athens.

Prof. Griveas Ioannis will present “New Perspectives in the Application of Immunoadsorption in Sepsis” at the 10th Hellenic Haemapheresis Association Conference.

Prof. George Dimopoulos will deliver a lecture on “Adsorption of Inflammatory Mediators in the Septic Patient” during the 20th Panhellenic Intensive Care Congress.

We invite everyone who works in sepsis care to join these events and learn more about an innovative therapy that is already helping patients.

Efferon is a next-generation hemoadsorption cartridge engineered to remove both endotoxins and cytokines from the bloodstream. It has received EU approval for use in sepsis patients under the MDR regulation. Today, Efferon LPS is available in more than 35 countries worldwide.